Ocugen (OCGN) Preferred Dividend Payments (2016 - 2020)
Ocugen posted quarterly Preferred Dividend Payments of $12.5 million for Q2 2020, up 59842.86% on a QoQ basis from -$21000.0 in Q1 2019.
Ocugen (OCGN) has 5 years of Preferred Dividend Payments data on file, last reported at $12.5 million in Q2 2020.
- For the quarter ending Q2 2020, Preferred Dividend Payments changed N/A year-over-year to $12.5 million; the trailing twelve-month figure through Jun 2021 stood at $12.5 million (changed 0.0% YoY), and the FY2020 full-year result was $12.5 million, changed N/A from the prior year.
- Preferred Dividend Payments for Q2 2020 stood at $12.5 million, up from -$21000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $12.5 million in Q2 2020 and bottomed at -$1.2 million in Q1 2017.
- The 5-year median for Preferred Dividend Payments is -$463000.0 (2018), against an average of $1.2 million.
- The widest annual swing landed in 2017, when Preferred Dividend Payments slumped 1029.63%; it then soared 95.46% in 2019.
- A 5-year view of Preferred Dividend Payments shows it stood at -$81000.0 in 2016, then plunged by 1029.63% to -$915000.0 in 2017, then surged by 49.4% to -$463000.0 in 2018, then jumped by 95.46% to -$21000.0 in 2019, then soared by 59842.86% to $12.5 million in 2020.
- The last three Preferred Dividend Payments figures came in at $12.5 million (Q2 2020), -$21000.0 (Q1 2019), and -$463000.0 (Q1 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 12.55 Mn |
| Mar 31, 2019 | -21,000.00 |
| Mar 31, 2018 | -463,000.00 |
| Sep 30, 2017 | -915,000.00 |
| Jun 30, 2017 | -1.09 Mn |
| Mar 31, 2017 | -1.25 Mn |
| Sep 30, 2016 | -81,000.00 |